Invention Grant
US08796426B2 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart
有权
抗EDb纤连蛋白抗体-IL-2融合蛋白与结合B细胞，B细胞祖细胞和/或其癌性对应物的分子的组合
- Patent Title: Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart
- Patent Title (中): 抗EDb纤连蛋白抗体-IL-2融合蛋白与结合B细胞，B细胞祖细胞和/或其癌性对应物的分子的组合
-
Application No.: US12270174Application Date: 2008-11-13
-
Publication No.: US08796426B2Publication Date: 2014-08-05
- Inventor: Dario Neri , Hans Dietrich Menssen , Andreas Menrad , Christoph Schliemann
- Applicant: Dario Neri , Hans Dietrich Menssen , Andreas Menrad , Christoph Schliemann
- Applicant Address: IT Sienna
- Assignee: Philogen S.p.A.
- Current Assignee: Philogen S.p.A.
- Current Assignee Address: IT Sienna
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP08075044 20080117
- Main IPC: C07K16/30
- IPC: C07K16/30 ; C07K14/55 ; C07K16/46 ; A61P35/00 ; A61P37/06
Abstract:
The present invention relates to a combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart and uses thereof.
Public/Granted literature
Information query
